BD Heats Up in Trispecifics, and China Wins Again
Trispecific BD: The Fire Has Just Been Lit
Time：
2026-05-06 18:49
Author：
xieyijun
IPO, Then Immediately Acquired: The New Playbook for Chinese NewCos
The "One-Fish-Multiple-Bites" Business
Time：
2026-05-04 18:36
Author：
xieyijun
Eli Lilly Builds Momentum: "A Thousand Gold for a Horse Bone"
The Strategic Positioning Behind the $21 Billion in Acquisitions
Time：
2026-05-03 19:50
Author：
xieyijun
Who is paying for pharmaceutical innovation?
Among all these, the hardest, slowest and latest to improve is the healthcare payment system.
Time：
2026-05-02 18:37
Author：
孟八一
Domestic Autoimmune Drugs Begin to Shine
Open the door to a hundred-billion-dollar market
Time：
2026-04-30 08:08
Author：
xieyijun
Recommended content
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
After rejecting a $30 billion acquisition offer, a biotech company has emerged as a giant
determination for independence
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务